NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-055-2011-0-NL-12 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE NL EP 13773456.2 Issued
NCI E-055-2011-0-ES-08 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE ES EP 13773456.2 Issued
NIAID E-135-2010-0-EP-04 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production EP National Stage 13712641.3 Issued
NIAID E-135-2010-0-IT-15 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IT EP 13712641.3 Issued
NIAID E-135-2010-0-IE-14 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IE EP 13712641.3 Issued
NIAID E-135-2010-0-NL-16 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production NL EP 13712641.3 Issued
NIAID E-135-2010-0-BE-09 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production BE EP 13712641.3 Issued
NIAID E-135-2010-0-CH-10 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production CH EP 13712641.3 Issued
NIAID E-135-2010-0-GB-13 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production GB EP 13712641.3 Issued
NIAID E-135-2010-0-DE-11 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production DE EP 13712641.3 Issued
NIAID E-135-2010-0-FR-12 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production FR EP 13712641.3 Issued
NIDDK E-091-2006-1-US-02 A3 Adenosine Receptor Allosteric Modulators US CON 13/800,560 9326978 Issued PDF
NIDCR E-257-2012-0-US-02 Methods Of Preventing The Development Of Mucositis And Related Disorders US ORD 13/798,863 9278090 Issued PDF
NIAID E-135-2010-0-PCT-02 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION PCT PCT PCT/US2013/030836 Expired
NCI E-111-2013-0-US-01 TetraHydroxamate Chelators of Zirconium89 For Use In Diagnostic Applications US 61/779,016 Abandoned
NIAID E-081-2013-0-US-01 Prefusion RSV F Proteins and Their Use US 61/780,910 Abandoned
NCI E-296-2011-0-US-01 Methods For Modulating Chemotherapeutic Cytotoxicity US 61/779,587 Abandoned
NLM E-107-2010-2-US-03 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 13/795,739 9447452 Issued PDF
NCI E-135-2012-0-PCT-02 DNA Methylation Analysis For The Diagnosis, Prognosis, and Treatment Of Adrenal Neoplasms PCT PCT PCT/US2013/030347 Expired
NEI E-283-2012-0-US-01 Methods For Using Lubiprostone To Absorb Fluid From The Subretinal Space US 61/777,073 Abandoned
NIMH E-262-2012-0-US-01 TRANSLOCATOR PROTEIN IMAGING AGENTS; METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF US 61/777,542 Abandoned
NIAAA E-049-2016-0-GB-01 COMPOUND FOR USE IN PROTECTING SKIN GB ORD 1304467.2 Abandoned
CC E-227-2012-1-US-01 System, Method And Device For Prostate Diagnosis And Intervention US 61/776,293 Abandoned
NIAID E-292-2010-2-US-02 Novel HIV-1 Broadly Neutralizing Antibodies US National Stage 13/792,098 9382311 Issued PDF
NIEHS E-080-2012-0-CA-03 USES OF ANTAGONISTS OF HYALURONAN SIGNALING CA National Stage 2872569 Issued
NIEHS E-080-2012-0-EP-04 USES OF ANTAGONISTS OF HYALURONAN SIGNALING EP National Stage 13790928.9 Issued
NIEHS E-080-2012-0-FR-07 USES OF ANTAGONISTS OF HYALURONAN SIGNALING FR EP 13790928.9 Issued
NIEHS E-080-2012-0-DE-06 USES OF ANTAGONISTS OF HYALURONAN SIGNALING DE EP 13790928.9 Issued
NIEHS E-080-2012-0-GB-08 USES OF ANTAGONISTS OF HYALURONAN SIGNALING GB EP 13790928.9 Issued
CC E-029-2011-2-GB-09 Therapeutic Apparatus And Method For Heating A Subject GB EP 11776898.6 Issued
CC E-029-2011-2-FR-08 Therapeutic Apparatus And Method For Heating A Subject FR EP 11776898.6 Issued
CC E-029-2011-2-DE-07 Therapeutic Apparatus And Method For Heating A Subject DE EP 11776898.6 Issued
NHGRI E-217-2007-0-US-08 N-acetyl Mannosamine as a Therapeutic Agent US CON 13/791,576 9095597 Issued PDF
NCI E-188-2010-1-US-01 Human Monoclonal Antibody Against Human Folate Receptor Beta US National Stage 13/790,881 8871206 Issued PDF
NIEHS E-080-2012-0-PCT-02 USES OF ANTAGONISTS OF HYALURONAN SIGNALING PCT PCT PCT/US2013/029776 Expired
NIDA E-073-2013-0-US-01 Potent and Selective Inhibitors Of Monoamine Transporters; Method of Making; and Use Thereof US 61/774,878 Abandoned
NCI E-281-2012-1-US-01 Inhibitors of the T Cell-Specific Alternative P38 Activation Pathway and Methods of Use US 61/774,066 Abandoned
NICHD E-098-2008-0-US-03 Methods of determining efficacy of cyclodextrin therapy US CON 13/786,757 9012216 Issued PDF
NCI E-078-2012-0-CA-04 Anti-Mesothelin Chimeric Antigen Receptors CA National Stage 2868121 Issued
NCI E-078-2012-0-EP-05 Anti-Mesothelin Chimeric Antigen Receptors EP National Stage 13717593.1 Issued
NCI E-269-2010-0-IL-08 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IL National Stage 225063 Issued
NCI E-234-2010-1-US-06 Biomarkers For Prostate Cancer And Methods For Their Detection US National Stage 13/814,337 9804163 Abandoned PDF
NCI E-078-2012-0-AU-03 Anti-Mesothelin Chimeric Antigen Receptors AU National Stage 2013235726 Issued
NCI E-078-2012-0-PCT-02 Anti-Mesothelin Chimeric Antigen Receptors PCT PCT PCT/US13/28980 Expired
NCI E-070-2013-1-US-01 Microfabricated Polymeric Silicone Hydrogel Vessel Mimetics US 61/773,064 Abandoned
NCI E-132-2012-0-ES-08 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions ES EP 13710247.1 Issued
NCI E-132-2012-0-DE-07 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions DE EP 13710247.1 Issued
NCI E-132-2012-0-FR-09 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions FR EP 13710247.1 Issued
NCI E-132-2012-0-GB-10 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions GB EP 13710247.1 Issued
NCI E-132-2012-0-CH-06 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions CH EP 13710247.1 Issued